Member Info for Borsaci06

obviously some do not like learning from past & applying on todays world

you find the answer ?

have anyone of you found out that

if INF I -III interferons upregulates TMPRS2 as well as Furin?

find the answer, we would know if sng001 is working or not against sars2

people have been taken to dry cleaners & got their pocket emptied :)

https://www.investegate.co.uk/physiomics-plc--pyc-/rns/holding-s--in-company/201801171552081812C/
https://www.investegate.co.uk/physiomics-plc--pyc-/rns/holding-s--in-company/201801251334359537C/

accumulated over weeks
people followed him buying
sp hit 13p
then he dumped all holdings
people relieased they have been taken to dry cleaners

Trapper1956
totally agree with you

lon Musk's Balls of Steel

@CultofNewMedia
so, after six months we know
*Covid-19 attacks T-cells like AIDS,
*blocks interferon,
*builds tentacles to inject RNA into neighboring cells and,
*now, mutates into potentially much more infectious forms.

https://twitter.com/CultofNewMedia/status/1277846653484105728

1p options to employees cover sp of 6p - 360p

yea sure,

sale is on until the release day of results.
wont be seeing COPD interims meanwhile

no worries,

sales will be on high street & on here SNG for next 31 days if lucky

AstraZeneca Presents Positive Data from Phase III ETHOS Trial of Triple-Combination Therapy Breztri Aerosphere in Moderate to Severe COPD

direct delivery of drug { inhailer/nebulizer } getting promoted, me thinks

Highlights

• Interferon treatment has shown mixed efficiency against SARS-CoV and MERS-CoV.
• SARS-CoV-2 is probably more sensitive to interferon than the other coronaviruses.
• The IFNß subtype appears to be the most suited for COVID-19 treatment.
• Interferon treatment should be performed in the early stages of the infection.
• Investigation on interferon-based COVID-19 treatment is warranted.

https://www.sciencedirect.com/science/article/pii/S0166354220302059

why selling 26 shares @46
barely covers commission

Day 2: COPD-ST2OP. Participants have completed all dosing visits & all 48 week primary outcome data has been collected
https://twitter.com/LeicesterCTU/status/1275324491606962176

quite
has everyone gone to Telegram?

dexamethasone, reduced death rates by a third for patients on ventilators, and by a fifth for patients needing oxygen

I think Acacia saw a potential in these 6 companies & derisked as you do.
there are 4 more biotech in which Link invested , but Acacia did not take over
ARIX
SENS
RENE
INHC

is it too early to assume they have stoped selling
as they have not issued any TR1 since 10.06.20

sng
mtph
orph
dddd
mph
trx

Ian
have look this rns

RNS Number : 8353N
Synairgen plc
26 May 2020

Richard Marsden, CEO of Synairgen, commented: "Over the coming months we will have three major clinical trial read-outs for SNG001, our wholly-owned, inhaled IFN-beta asset:

COPD patients with regular seasonal viruses;
COVID-19 hospital-treated patients; and
the early treatment of COVID-19 patients in the home setting.

The Company is active on many fronts from designing and managing novel trials to developing the regulatory strategy and supply chain for potential demand in the future."